Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697894 | Clinical Oncology | 2016 | 11 Pages |
Abstract
A satisfactory 5 year outcome with an acceptable toxicity profile was observed. The combination of image-guided radiotherapy-intensity-modulated radiotherapy, high equivalent 2Â Gy dose (EQD2) with a moderate hypofractionated approach and extensive prophylactic lymph node irradiation also leads to very good outcome in high-risk patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
N.G. Di Muzio, A. Fodor, B. Noris Chiorda, S. Broggi, P. Mangili, R. Valdagni, I. Dell'Oca, M. Pasetti, C.L. Deantoni, A. Chiara, G. Berardi, A. Briganti, R. Calandrino, C. Cozzarini, C. Fiorino,